2014 Q2 Form 10-Q Financial Statement
#000110465914058802 Filed on August 08, 2014
Income Statement
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| Revenue | $457.4M | $552.1M | $454.9M |
| YoY Change | 0.55% | 6.73% | 8.13% |
| Cost Of Revenue | $256.9M | $316.2M | $253.3M |
| YoY Change | 1.42% | 14.73% | 8.95% |
| Gross Profit | $200.5M | $235.9M | $201.6M |
| YoY Change | -0.55% | -2.4% | 7.41% |
| Gross Profit Margin | 43.83% | 42.73% | 44.32% |
| Selling, General & Admin | $115.0M | $119.1M | $107.1M |
| YoY Change | 7.38% | -6.15% | -3.16% |
| % of Gross Profit | 57.36% | 50.49% | 53.13% |
| Research & Development | $44.50M | $49.10M | $46.50M |
| YoY Change | -4.3% | -2.39% | -10.4% |
| % of Gross Profit | 22.19% | 20.81% | 23.07% |
| Depreciation & Amortization | $14.80M | $15.90M | $15.00M |
| YoY Change | -1.33% | -4.22% | 0.0% |
| % of Gross Profit | 7.38% | 6.74% | 7.44% |
| Operating Expenses | $165.1M | $168.2M | $158.1M |
| YoY Change | 4.43% | -5.29% | -4.82% |
| Operating Profit | $35.40M | $61.00M | $43.50M |
| YoY Change | -18.62% | 55.61% | 96.83% |
| Interest Expense | $3.100M | -$6.600M | $3.100M |
| YoY Change | 0.0% | 13.79% | -11.43% |
| % of Operating Profit | 8.76% | -10.82% | 7.13% |
| Other Income/Expense, Net | $800.0K | -$600.0K | -$7.800M |
| YoY Change | -110.26% | -154.55% | 178.57% |
| Pretax Income | $33.10M | $53.80M | $35.70M |
| YoY Change | -7.28% | 55.94% | 84.97% |
| Income Tax | $16.30M | $17.90M | $12.40M |
| % Of Pretax Income | 49.24% | 33.27% | 34.73% |
| Net Earnings | $16.40M | $35.20M | $22.90M |
| YoY Change | -28.38% | 175.0% | 131.31% |
| Net Earnings / Revenue | 3.59% | 6.38% | 5.03% |
| Basic Earnings Per Share | $0.21 | $0.14 | |
| Diluted Earnings Per Share | $96.76K | $0.21 | $0.14 |
| COMMON SHARES | |||
| Basic Shares Outstanding | 167.6M shares | 167.6M shares | 166.8M shares |
| Diluted Shares Outstanding | 169.5M shares | 168.4M shares |
Balance Sheet
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| SHORT-TERM ASSETS | |||
| Cash & Short-Term Investments | $457.6M | $438.7M | $250.9M |
| YoY Change | 82.38% | 41.24% | 4.41% |
| Cash & Equivalents | $389.8M | $438.7M | $250.9M |
| Short-Term Investments | $67.80M | ||
| Other Short-Term Assets | $116.1M | $95.80M | $110.6M |
| YoY Change | 4.97% | 3.57% | 7.69% |
| Inventory | $612.1M | $589.8M | $601.8M |
| Prepaid Expenses | |||
| Receivables | $279.6M | $307.6M | $300.5M |
| Other Receivables | $0.00 | $0.00 | $0.00 |
| Total Short-Term Assets | $1.465B | $1.432B | $1.264B |
| YoY Change | 15.95% | 9.33% | 4.27% |
| LONG-TERM ASSETS | |||
| Property, Plant & Equipment | $293.4M | $299.5M | $287.8M |
| YoY Change | 1.95% | 5.61% | 11.08% |
| Goodwill | $126.9M | $127.4M | $115.6M |
| YoY Change | 9.78% | 9.92% | 5.28% |
| Intangibles | $95.60M | $105.6M | $106.1M |
| YoY Change | -9.9% | -9.74% | -23.39% |
| Long-Term Investments | |||
| YoY Change | |||
| Other Assets | $5.200M | ||
| YoY Change | -58.73% | ||
| Total Long-Term Assets | $538.5M | $556.4M | $538.0M |
| YoY Change | 0.09% | 1.77% | 0.0% |
| TOTAL ASSETS | |||
| Total Short-Term Assets | $1.465B | $1.432B | $1.264B |
| Total Long-Term Assets | $538.5M | $556.4M | $538.0M |
| Total Assets | $2.004B | $1.988B | $1.802B |
| YoY Change | 11.22% | 7.11% | 2.95% |
| SHORT-TERM LIABILITIES | |||
| YoY Change | |||
| Accounts Payable | $102.2M | $74.80M | $69.50M |
| YoY Change | 47.05% | 7.47% | -10.21% |
| Accrued Expenses | $172.9M | ||
| YoY Change | 4.85% | ||
| Deferred Revenue | |||
| YoY Change | |||
| Short-Term Debt | $0.00 | $0.00 | $0.00 |
| YoY Change | |||
| Long-Term Debt Due | $800.0K | $700.0K | $1.100M |
| YoY Change | -27.27% | -46.15% | -98.58% |
| Total Short-Term Liabilities | $628.5M | $648.6M | $602.8M |
| YoY Change | 4.26% | -4.87% | -19.83% |
| LONG-TERM LIABILITIES | |||
| Long-Term Debt | $354.9M | $354.3M | $335.4M |
| YoY Change | 5.81% | 5.48% | 37.85% |
| Other Long-Term Liabilities | $135.1M | $135.2M | $140.9M |
| YoY Change | -4.12% | 514.55% | 24.36% |
| Total Long-Term Liabilities | $135.1M | $135.2M | $476.3M |
| YoY Change | -71.64% | 514.55% | 33.57% |
| TOTAL LIABILITIES | |||
| Total Short-Term Liabilities | $628.5M | $648.6M | $602.8M |
| Total Long-Term Liabilities | $135.1M | $135.2M | $476.3M |
| Total Liabilities | $763.6M | $783.8M | $1.083B |
| YoY Change | -29.49% | 11.37% | -2.56% |
| SHAREHOLDERS EQUITY | |||
| Retained Earnings | $599.1M | ||
| YoY Change | 15.43% | ||
| Common Stock | $63.50M | ||
| YoY Change | 31.47% | ||
| Preferred Stock | |||
| YoY Change | |||
| Treasury Stock (at cost) | $600.0K | $600.0K | |
| YoY Change | 200.0% | ||
| Treasury Stock Shares | 41.87K shares | 39.84K shares | 32.65K shares |
| Shareholders Equity | $880.3M | $846.1M | $718.9M |
| YoY Change | |||
| Total Liabilities & Shareholders Equity | $2.004B | $1.988B | $1.802B |
| YoY Change | 11.22% | 7.11% | 2.95% |
Cashflow Statement
| Concept | 2014 Q2 | 2013 Q4 | 2013 Q2 |
|---|---|---|---|
| OPERATING ACTIVITIES | |||
| Net Income | $16.40M | $35.20M | $22.90M |
| YoY Change | -28.38% | 175.0% | 131.31% |
| Depreciation, Depletion And Amortization | $14.80M | $15.90M | $15.00M |
| YoY Change | -1.33% | -4.22% | 0.0% |
| Cash From Operating Activities | $13.00M | $131.4M | -$6.700M |
| YoY Change | -294.03% | 44.55% | -118.06% |
| INVESTING ACTIVITIES | |||
| Capital Expenditures | -$7.600M | -$9.000M | -$16.50M |
| YoY Change | -53.94% | -60.87% | -12.23% |
| Acquisitions | |||
| YoY Change | |||
| Other Investing Activities | -$67.30M | $600.0K | -$1.300M |
| YoY Change | 5076.92% | -113.33% | -244.44% |
| Cash From Investing Activities | -$74.90M | -$8.400M | -$17.80M |
| YoY Change | 320.79% | -69.45% | -0.56% |
| FINANCING ACTIVITIES | |||
| Cash Dividend Paid | |||
| YoY Change | |||
| Common Stock Issuance & Retirement, Net | |||
| YoY Change | |||
| Debt Paid & Issued, Net | |||
| YoY Change | |||
| Cash From Financing Activities | 700.0K | 1.700M | 2.400M |
| YoY Change | -70.83% | 41.67% | -11.11% |
| NET CHANGE | |||
| Cash From Operating Activities | 13.00M | 131.4M | -6.700M |
| Cash From Investing Activities | -74.90M | -8.400M | -17.80M |
| Cash From Financing Activities | 700.0K | 1.700M | 2.400M |
| Net Change In Cash | -61.20M | 124.7M | -22.10M |
| YoY Change | 176.92% | 93.03% | -200.91% |
| FREE CASH FLOW | |||
| Cash From Operating Activities | $13.00M | $131.4M | -$6.700M |
| Capital Expenditures | -$7.600M | -$9.000M | -$16.50M |
| Free Cash Flow | $20.60M | $140.4M | $9.800M |
| YoY Change | 110.2% | 23.27% | -82.47% |
Facts In Submission
| Frame | Concept Type | Concept / XBRL Key | Value | Unit |
|---|---|---|---|---|
| us-gaap |
Nature Of Operations
NatureOfOperations
|
<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="TEXT-INDENT: -0.25in; MARGIN: 0in 0in 0pt 0.25in;"><b><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">1.</font></b><b><font style="FONT-SIZE: 3pt; FONT-WEIGHT: bold;" size="1">             </font></b> <b><font style="FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Description of Business</font></b></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker Corporation, together with its consolidated subsidiaries (‘‘Bruker’’ or the ‘‘Company’’), is a designer, manufacturer and distributor of proprietary life science and materials research systems and associated products that address the rapidly evolving needs of a diverse array of customers in life science, pharmaceutical, biotechnology, clinical and molecular diagnostics research, and materials and chemical analysis in various industries and government applications.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company has two reporting segments, <i>Bruker Scientific Instruments (BSI)</i>, which represents approximately 93% of the Company’s revenues during the six months ended June 30, 2014, and <i>Bruker Energy & Supercon Technologies (BEST)</i>, which represents the remainder of the Company’s revenues.  Within BSI, the Company is organized into three operating segments: the Bruker BioSpin Group, the Bruker CALID Group and the Bruker MAT Group. For financial reporting purposes, the Bruker BioSpin, Bruker CALID and Bruker MAT operating segments are aggregated into the BSI reporting segment because each has similar economic characteristics, production processes, service offerings, types and classes of customers, methods of distribution and regulatory environments.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker BioSpin</font></i><font style="FONT-SIZE: 10pt;" size="2">- Bruker BioSpin designs, manufactures and distributes enabling life science tools based on magnetic resonance and preclinical imaging technologies. Bruker BioSpin’s Magnetic Resonance division sells various systems utilizing magnetic resonance technology, including magnetic resonance imaging (MRI) systems, nuclear magnetic resonance systems (NMR), and electron paramagnetic resonance systems (EPR), as well as OEM MRI magnets sold to medical device manufacturers. Bruker BioSpin’s Preclinical Imaging division sells single and multiple modality systems using MRI, position emission tomography (PET), single photon emission tomography (SPECT), computed tomography (CT), magnetic particle imaging (MPI) and optical imaging (fluorescence and bioluminescence) technologies to preclinical markets.</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;"> </p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker CALID (<u>C</u>hemicals, <u>A</u>pplied Markets, <u>L</u>ife Science, <u>I</u>n-Vitro Diagnostics, <u>D</u>etection)</font></i><font style="FONT-SIZE: 10pt;" size="2">- Bruker CALID designs, manufactures and distributes life science mass spectrometry instruments that can be integrated and used along with other sample preparation or chromatography instruments, as well as Chemical, Biological, Radiological, Nuclear and Explosive (CBRNE) detection products.  Bruker CALID also designs, manufactures and distributes instruments based on Raman molecular spectroscopy technologies. Bruker CALID’s mass spectrometry units are typically used in applications of expression proteomics, clinical proteomics, metabolic and peptide biomarker profiling, drug discovery and development, molecular diagnostics research, molecular and systems biology, basic molecular medicine research and clinical microbiology (for research use only outside the European Union).</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;"> </p> <p style="MARGIN: 0in 0in 0pt 0.25in;"><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">Bruker MAT (Materials)</font></i><font style="FONT-SIZE: 10pt;" size="2">- Bruker MAT designs, manufactures and distributes spectroscopy and microscopy instruments for the understanding of composition and structure in material science and life science samples.  The instruments are based on advanced technologies in X-ray fluorescence spectroscopy (XRF), X-ray diffraction (XRD), X-ray micro computed tomography (μCT), atomic force microscopy (AFM), stylus and optical metrology (SOM) and fluorescence microscopy (FM), and also include analytical tools for electron microscopes, handheld, portable, and mobile X-ray fluorescence, and spark optical emission spectroscopy systems.</font></p> <p style="MARGIN: 0in 0in 0pt 0.25in;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The Company’s BEST reporting segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and ‘‘big science’’ research. The segment focuses on metallic low temperature superconductors for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications, and ceramic high temperature superconductors primarily for energy grid and magnet applications.</font></p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The unaudited condensed consolidated financial statements represent the consolidated accounts of the Company. All significant intercompany accounts and transactions have been eliminated in consolidation. The unaudited condensed consolidated financial statements as of June 30, 2014 and December 31, 2013 and for the three and six months ended June 30, 2014 and 2013, have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X. Accordingly, the financial information presented herein does not include all of the information and footnotes required by GAAP for complete financial statements. In the opinion of management, all adjustments, consisting only of normal recurring adjustments, considered necessary for a fair presentation have been included. The results for interim periods are not necessarily indicative of the results expected for any other interim period or the full year.</font></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.25in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">At June 30, 2014, the Company’s significant accounting policies and estimates, which are detailed in the Company’s Annual Report on Form 10-K for the year ended December 31, 2013, have not changed.</font></p> </div> | ||
| CY2014Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
16400000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
22900000 | USD |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
167600000 | shares |
| CY2013Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
1400000 | USD |
| CY2014Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3000000 | USD |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
5000000 | USD | |
| us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
3200000 | USD | |
| CY2014Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
628500000 | USD |
| us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
28300000 | USD | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
166800000 | shares |
| us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
166600000 | shares | |
| CY2014Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1900000 | shares |
| CY2013Q2 | us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1600000 | shares |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1900000 | shares | |
| us-gaap |
Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
|
1600000 | shares | |
| CY2014Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
169500000 | shares |
| us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
169400000 | shares | |
| CY2013Q2 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
168400000 | shares |
| CY2014Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.10 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.15 | ||
| CY2013Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.14 | |
| us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.17 | ||
| CY2014Q2 | us-gaap |
Availableforsale Securities Gross Unrealized Gain Loss1
AvailableforsaleSecuritiesGrossUnrealizedGainLoss1
|
0 | USD |
| CY2013Q4 | us-gaap |
Inventory Net
InventoryNet
|
589800000 | USD |
| CY2014Q2 | us-gaap |
Other Inventory In Transit
OtherInventoryInTransit
|
71500000 | USD |
| CY2014Q2 | us-gaap |
Goodwill
Goodwill
|
126900000 | USD |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10200000 | USD | |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
176100000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
|
175800000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
76200000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
|
85900000 | USD |
| CY2013Q4 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
99900000 | USD |
| CY2014Q2 | us-gaap |
Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
|
89900000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
181800000 | USD |
| CY2014Q2 | us-gaap |
Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
|
181500000 | USD |
| CY2013Q4 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
105600000 | USD |
| CY2014Q2 | us-gaap |
Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
|
95600000 | USD |
| CY2014Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
4800000 | USD |
| CY2013Q4 | us-gaap |
Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
|
189700000 | USD |
| CY2014Q2 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
200800000 | USD |
| CY2013Q4 | us-gaap |
Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
|
196500000 | USD |
| CY2014Q2 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
158200000 | USD |
| CY2013Q4 | us-gaap |
Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
|
155300000 | USD |
| CY2014Q2 | us-gaap |
Other Inventory Demo
OtherInventoryDemo
|
52700000 | USD |
| CY2013Q4 | us-gaap |
Other Inventory Demo
OtherInventoryDemo
|
48300000 | USD |
| CY2014Q2 | us-gaap |
Inventory Net
InventoryNet
|
612100000 | USD |
| CY2013Q2 | us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
5100000 | USD |
| us-gaap |
Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
|
10000000 | USD | |
| dei |
Entity Registrant Name
EntityRegistrantName
|
BRUKER CORP | ||
| dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001109354 | ||
| dei |
Document Type
DocumentType
|
10-Q | ||
| dei |
Document Period End Date
DocumentPeriodEndDate
|
2014-06-30 | ||
| dei |
Amendment Flag
AmendmentFlag
|
false | ||
| dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
| dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
| dei |
Entity Filer Category
EntityFilerCategory
|
Large Accelerated Filer | ||
| CY2014Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
168056129 | shares |
| dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2014 | ||
| dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-600000 | USD | |
| us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
700000 | USD | |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
14100000 | USD |
| CY2014Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
|
4000000 | USD |
| us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.451 | pure | |
| CY2014Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
33300000 | USD |
| CY2013Q4 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
32700000 | USD |
| CY2014Q2 | us-gaap |
Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
|
14000000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt
LongTermDebt
|
355000000 | USD |
| CY2014Q2 | us-gaap |
Long Term Debt
LongTermDebt
|
355700000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
700000 | USD |
| CY2014Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
|
800000 | USD |
| CY2013Q4 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
354300000 | USD |
| CY2014Q2 | us-gaap |
Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
|
354900000 | USD |
| brkr |
Other Comprehensive Income Loss Other Adjustment Net Of Tax
OtherComprehensiveIncomeLossOtherAdjustmentNetOfTax
|
300000 | USD | |
| CY2014Q2 | brkr |
Noncontrolling Interest Other Increase Decrease
NoncontrollingInterestOtherIncreaseDecrease
|
100000 | USD |
| brkr |
Noncontrolling Interest Other Increase Decrease
NoncontrollingInterestOtherIncreaseDecrease
|
400000 | USD | |
| CY2014Q2 | us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
700000 | USD |
| us-gaap |
Information Technology And Data Processing
InformationTechnologyAndDataProcessing
|
1300000 | USD | |
| CY2014Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
16300000 | USD |
| CY2013Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
12400000 | USD |
| CY2014Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.492 | pure |
| CY2013Q2 | us-gaap |
Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
|
0.347 | pure |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
4700000 | USD | |
| us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | USD | |
| CY2014Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
0 | USD |
| CY2013Q2 | us-gaap |
Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
|
400000 | USD |
| CY2014Q2 | us-gaap |
Profit Loss
ProfitLoss
|
16800000 | USD |
| CY2013Q2 | us-gaap |
Profit Loss
ProfitLoss
|
23300000 | USD |
| us-gaap |
Profit Loss
ProfitLoss
|
26800000 | USD | |
| us-gaap |
Profit Loss
ProfitLoss
|
29000000 | USD | |
| CY2014Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-3500000 | USD |
| CY2013Q2 | us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
4300000 | USD |
| us-gaap |
Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
|
-25300000 | USD | |
| CY2013Q2 | us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-700000 | USD |
| us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
100000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
|
-1700000 | USD | |
| CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
13300000 | USD |
| CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
28300000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
26400000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
5400000 | USD | |
| CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
500000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
22900000 | USD |
| CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
400000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
2100000 | USD | |
| us-gaap |
Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
700000 | USD | |
| CY2014Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
12800000 | USD |
| CY2013Q2 | us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
27900000 | USD |
| us-gaap |
Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
|
24300000 | USD | |
| CY2013Q4 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
182400000 | USD |
| CY2014Q2 | us-gaap |
Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
181700000 | USD |
| CY2012Q4 | us-gaap |
Minority Interest
MinorityInterest
|
3100000 | USD |
| CY2013Q2 | us-gaap |
Minority Interest
MinorityInterest
|
3800000 | USD |
| CY2013Q4 | us-gaap |
Minority Interest
MinorityInterest
|
4100000 | USD |
| CY2013Q1 | us-gaap |
Minority Interest
MinorityInterest
|
3400000 | USD |
| CY2014Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
400000 | USD |
| CY2014Q1 | us-gaap |
Minority Interest
MinorityInterest
|
5700000 | USD |
| CY2013Q2 | us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
400000 | USD |
| us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
1700000 | USD | |
| us-gaap |
Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
|
700000 | USD | |
| CY2014Q2 | us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
1100000 | USD |
| us-gaap |
Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
1100000 | USD | |
| CY2014Q2 | us-gaap |
Assets Current
AssetsCurrent
|
1465400000 | USD |
| CY2014Q2 | us-gaap |
Legal Fees
LegalFees
|
600000 | USD |
| CY2013Q2 | us-gaap |
Legal Fees
LegalFees
|
2400000 | USD |
| us-gaap |
Legal Fees
LegalFees
|
2800000 | USD | |
| us-gaap |
Legal Fees
LegalFees
|
4600000 | USD | |
| CY2013Q2 | brkr |
Factory Relocation Charges
FactoryRelocationCharges
|
200000 | USD |
| brkr |
Factory Relocation Charges
FactoryRelocationCharges
|
500000 | USD | |
| CY2014Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
16400000 | USD |
| CY2014Q2 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
300000 | USD |
| CY2013Q2 | us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
100000 | USD |
| us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
900000 | USD | |
| us-gaap |
Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
|
500000 | USD | |
| CY2014Q2 | brkr |
Restructuring Charges Excluding Cost Of Sales
RestructuringChargesExcludingCostOfSales
|
4000000 | USD |
| CY2013Q2 | brkr |
Restructuring Charges Excluding Cost Of Sales
RestructuringChargesExcludingCostOfSales
|
1800000 | USD |
| brkr |
Restructuring Charges Excluding Cost Of Sales
RestructuringChargesExcludingCostOfSales
|
4200000 | USD | |
| brkr |
Restructuring Charges Excluding Cost Of Sales
RestructuringChargesExcludingCostOfSales
|
5000000 | USD | |
| CY2014Q2 | us-gaap |
Other Nonrecurring Expense
OtherNonrecurringExpense
|
5600000 | USD |
| CY2013Q4 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
258600000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
314500000 | USD |
| CY2013Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
648600000 | USD |
| CY2013Q2 | us-gaap |
Other Nonrecurring Expense
OtherNonrecurringExpense
|
4500000 | USD |
| us-gaap |
Other Nonrecurring Expense
OtherNonrecurringExpense
|
9200000 | USD | |
| us-gaap |
Other Nonrecurring Expense
OtherNonrecurringExpense
|
10600000 | USD | |
| CY2013Q4 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
11500000 | USD |
| CY2014Q2 | us-gaap |
Restructuring Reserve
RestructuringReserve
|
12100000 | USD |
| us-gaap |
Restructuring Charges
RestructuringCharges
|
13100000 | USD | |
| us-gaap |
Payments For Restructuring
PaymentsForRestructuring
|
10500000 | USD | |
| us-gaap |
Restructuring Reserve Accrual Adjustment
RestructuringReserveAccrualAdjustment
|
-2000000 | USD | |
| CY2014Q2 | us-gaap |
Interest Expense
InterestExpense
|
3100000 | USD |
| CY2013Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-4700000 | USD |
| CY2013Q2 | us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7800000 | USD |
| us-gaap |
Interest Expense
InterestExpense
|
6100000 | USD | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-1600000 | USD | |
| us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
300000 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-7200000 | USD | |
| us-gaap |
Interest Expense
InterestExpense
|
6200000 | USD | |
| us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-5100000 | USD | |
| us-gaap |
Gain Loss On Sale Of Business
GainLossOnSaleOfBusiness
|
900000 | USD | |
| us-gaap |
Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
|
-1300000 | USD | |
| us-gaap |
Nonoperating Income Expense
NonoperatingIncomeExpense
|
-11700000 | USD | |
| CY2014Q2 | us-gaap |
Revenues
Revenues
|
457400000 | USD |
| CY2013Q2 | us-gaap |
Revenues
Revenues
|
454900000 | USD |
| us-gaap |
Revenues
Revenues
|
881100000 | USD | |
| us-gaap |
Revenues
Revenues
|
848300000 | USD | |
| CY2014Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
35400000 | USD |
| CY2013Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
43500000 | USD |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
56000000 | USD | |
| us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
55700000 | USD | |
| CY2013Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
217000000 | USD |
| CY2014Q2 | us-gaap |
Assets
Assets
|
2003900000 | USD |
| CY2013Q4 | us-gaap |
Assets
Assets
|
1988300000 | USD |
| CY2013Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
307600000 | USD |
| CY2013Q4 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
95800000 | USD |
| CY2013Q4 | us-gaap |
Assets Current
AssetsCurrent
|
1431900000 | USD |
| CY2013Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
74800000 | USD |
| CY2013Q4 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
299500000 | USD |
| CY2013Q4 | brkr |
Intangibles And Other Long Term Assets Noncurrent
IntangiblesAndOtherLongTermAssetsNoncurrent
|
256900000 | USD |
| CY2013Q4 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
135200000 | USD |
| CY2013Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2014Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
| CY2013Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2014Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
USD | |
| CY2013Q4 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
1700000 | USD |
| CY2013Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
600000 | USD |
| CY2013Q4 | brkr |
Others Shareholders Equity
OthersShareholdersEquity
|
662600000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
846100000 | USD |
| CY2013Q4 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
850200000 | USD |
| CY2013Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
1988300000 | USD |
| CY2014Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
2003900000 | USD |
| CY2014Q2 | us-gaap |
Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
885400000 | USD |
| CY2014Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
| CY2014Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
| CY2013Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
| CY2014Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2013Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.01 | |
| CY2014Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
260000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
260000000 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
167619039 | shares |
| CY2014Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
168056129 | shares |
| CY2013Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
167579204 | shares |
| CY2014Q2 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
41866 | shares |
| CY2013Q4 | us-gaap |
Treasury Stock Shares
TreasuryStockShares
|
39835 | shares |
| CY2013Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
395600000 | USD |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
734900000 | USD | |
| CY2013Q2 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
52700000 | USD |
| us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
106200000 | USD | |
| CY2013Q2 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
6600000 | USD |
| us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
7200000 | USD | |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
402300000 | USD | |
| CY2013Q2 | us-gaap |
Cost Of Services
CostOfServices
|
36300000 | USD |
| us-gaap |
Cost Of Services
CostOfServices
|
69900000 | USD | |
| CY2013Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
253300000 | USD |
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
472200000 | USD | |
| CY2013Q2 | us-gaap |
Gross Profit
GrossProfit
|
201600000 | USD |
| us-gaap |
Gross Profit
GrossProfit
|
376100000 | USD | |
| CY2013Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
107100000 | USD |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
213900000 | USD | |
| CY2013Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
46500000 | USD |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
95900000 | USD | |
| CY2013Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
158100000 | USD |
| us-gaap |
Operating Expenses
OperatingExpenses
|
320400000 | USD | |
| CY2013Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
35700000 | USD |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
44000000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
28300000 | USD | |
| CY2014Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
279600000 | USD |
| us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
13400000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
5000000 | USD | |
| us-gaap |
Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
|
-21900000 | USD | |
| us-gaap |
Net Income Loss
NetIncomeLoss
|
25100000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
30200000 | USD | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
16000000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
3200000 | USD | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
-2600000 | USD | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
600000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
20900000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
21900000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-14100000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
-12900000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-24900000 | USD | |
| us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
31500000 | USD | |
| us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
500000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
31100000 | USD | |
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
600000 | USD | |
| us-gaap |
Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
|
2100000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-32100000 | USD | |
| us-gaap |
Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
-82800000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-800000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
3200000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
500000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4500000 | USD | |
| us-gaap |
Proceeds From Repayments Of Restricted Cash Financing Activities
ProceedsFromRepaymentsOfRestrictedCashFinancingActivities
|
-1300000 | USD | |
| us-gaap |
Payments To Minority Shareholders
PaymentsToMinorityShareholders
|
1100000 | USD | |
| us-gaap |
Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations
EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations
|
-5400000 | USD | |
| us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
2700000 | USD | |
| us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-59700000 | USD | |
| us-gaap |
Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
|
-48900000 | USD | |
| us-gaap |
Goodwill Other Changes
GoodwillOtherChanges
|
100000 | USD | |
| us-gaap |
Goodwill Translation Adjustments
GoodwillTranslationAdjustments
|
-400000 | USD | |
| us-gaap |
Payments To Acquire Marketable Securities
PaymentsToAcquireMarketableSecurities
|
67800000 | USD | |
| us-gaap |
Other Comprehensive Income Loss Before Reclassifications Net Of Tax
OtherComprehensiveIncomeLossBeforeReclassificationsNetOfTax
|
-700000 | USD | |
| CY2014Q2 | us-gaap |
Minority Interest
MinorityInterest
|
5100000 | USD |
| CY2014Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
389800000 | USD |
| CY2012Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
310600000 | USD |
| CY2013Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
250900000 | USD |
| CY2014Q2 | us-gaap |
Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
|
67800000 | USD |
| CY2013Q4 | us-gaap |
Goodwill
Goodwill
|
127400000 | USD |
| CY2014Q2 | brkr |
Intangibles And Other Long Term Assets Noncurrent
IntangiblesAndOtherLongTermAssetsNoncurrent
|
245100000 | USD |
| CY2014Q2 | us-gaap |
Other Assets Current
OtherAssetsCurrent
|
116100000 | USD |
| CY2014Q2 | us-gaap |
Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
|
293400000 | USD |
| CY2014Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
102200000 | USD |
| CY2014Q2 | us-gaap |
Customer Advances Current
CustomerAdvancesCurrent
|
223500000 | USD |
| CY2014Q2 | us-gaap |
Other Liabilities Current
OtherLiabilitiesCurrent
|
302000000 | USD |
| CY2014Q2 | us-gaap |
Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
|
135100000 | USD |
| CY2014Q2 | us-gaap |
Common Stock Value Outstanding
CommonStockValueOutstanding
|
1700000 | USD |
| CY2014Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
600000 | USD |
| CY2014Q2 | brkr |
Others Shareholders Equity
OthersShareholdersEquity
|
697500000 | USD |
| CY2014Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
880300000 | USD |
| CY2014Q2 | us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
398900000 | USD |
| CY2014Q2 | us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
57700000 | USD |
| CY2014Q2 | us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
800000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
217200000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Services
CostOfServices
|
39700000 | USD |
| CY2014Q2 | us-gaap |
Cost Of Revenue
CostOfRevenue
|
256900000 | USD |
| CY2014Q2 | us-gaap |
Gross Profit
GrossProfit
|
200500000 | USD |
| CY2014Q2 | us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
115000000 | USD |
| CY2014Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
44500000 | USD |
| CY2014Q2 | us-gaap |
Operating Expenses
OperatingExpenses
|
165100000 | USD |
| CY2014Q2 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
33100000 | USD |
| us-gaap |
Sales Revenue Goods Net
SalesRevenueGoodsNet
|
765000000 | USD | |
| us-gaap |
Sales Revenue Services Net
SalesRevenueServicesNet
|
114700000 | USD | |
| us-gaap |
Other Sales Revenue Net
OtherSalesRevenueNet
|
1400000 | USD | |
| us-gaap |
Cost Of Goods Sold
CostOfGoodsSold
|
424300000 | USD | |
| us-gaap |
Cost Of Services
CostOfServices
|
76600000 | USD | |
| us-gaap |
Cost Of Revenue
CostOfRevenue
|
500900000 | USD | |
| us-gaap |
Gross Profit
GrossProfit
|
380200000 | USD | |
| us-gaap |
Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
|
224500000 | USD | |
| us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
90500000 | USD | |
| us-gaap |
Operating Expenses
OperatingExpenses
|
324200000 | USD | |
| us-gaap |
Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
|
48800000 | USD | |
| us-gaap |
Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
|
30000000 | USD | |
| us-gaap |
Inventory Write Down
InventoryWriteDown
|
15200000 | USD | |
| us-gaap |
Share Based Compensation
ShareBasedCompensation
|
5000000 | USD | |
| us-gaap |
Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
|
300000 | USD | |
| us-gaap |
Other Noncash Income Expense
OtherNoncashIncomeExpense
|
-1200000 | USD | |
| us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-28900000 | USD | |
| us-gaap |
Increase Decrease In Inventories
IncreaseDecreaseInInventories
|
38400000 | USD | |
| us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
8900000 | USD | |
| us-gaap |
Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
|
8800000 | USD | |
| us-gaap |
Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
|
1900000 | USD | |
| us-gaap |
Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
|
-34800000 | USD | |
| us-gaap |
Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
|
22300000 | USD | |
| us-gaap |
Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
|
700000 | USD | |
| us-gaap |
Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
|
16800000 | USD | |
| us-gaap |
Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
|
1100000 | USD | |
| us-gaap |
Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
|
500000 | USD | |
| us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
4800000 | USD |
